Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Thymalin Peptide vs Thymulin: Direct Molecular Comparison

Molecular Structure Multi-peptide extract (1–10 kDa) containing thymopoietin fragments, thymosin-like sequences, and uncharacterised short peptides Single nonapeptide (Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn, MW 858 Da) Thymalin is a complex mixture; thymulin is a

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Molecular Structure
  • Multi-peptide extract (1–10 kDa) containing thymopoietin fragments, thymosin-like sequences, and uncharacterised short peptides
  • Single nonapeptide (Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn, MW 858 Da)
  • Thymalin is a complex mixture; thymulin is a defined sequence. Fundamentally different analytical profiles
  • Synthesis Method
  • Acid or enzymatic hydrolysis of calf thymus tissue
  • Chemical peptide synthesis (Fmoc or Boc strategy)
  • Thymalin requires animal tissue; thymulin can be produced entirely synthetically
  • Zinc Dependency
  • No zinc cofactor required for activity
  • Requires Zn²⁺ binding for biological function
  • Thymalin functions independently of zinc; thymulin is inactive without metalloprotein complex
  • Regulatory Status
  • Approved pharmaceutical in Russia/Kazakhstan; unregulated research peptide in most other jurisdictions
  • Endogenous hormone (not regulated as exogenous drug); synthetic analogs are research-use only globally
  • Thymalin has clinical approval in Eastern Europe; thymulin has no approved therapeutic formulation anywhere
  • Primary Mechanism
  • Promotes T-cell differentiation via thymic stromal peptide mimicry
  • Modulates T-cell maturation through zinc-dependent receptor binding in thymic cortex
  • Both support thymopoiesis but through different molecular pathways
  • Typical Dosage (Research)
  • 10–30 mg IM injection (clinical); 1–5 mg/kg in animal models
  • 0.1–1 µg/kg (synthetic analog dosing in experimental models)
  • Thymalin is administered in milligram quantities; thymulin analogs use microgram dosing. Orders of magnitude difference